Advanced Glycation end Products: Specific Fluorescence Changes of Pentosidine-Like Compounds during Short Daily Hemodialysis

Pongor S. , Ulrich P.C. , Bencsath F.A. , Cerami A. Aging of proteins: isolation and identification of a fluorescent chromofore from the reaction of polypeptides with glucose. Proc Natl Acad Sci 1984; 81: 2684–8.

Famar J. , Ulrich P. , Cerami A. Novel pyrroles from sulfite-inhibited Maillard reactions: insights into the mechanisms of inhibition. J Org Chem 1988; 53: 2346–9.

Nioroge F.C. , Sayre L.M. , Monnier V.M. Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res 1987; 167: 211–20.

Sell D.R. , Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 1989; 264: 21597–602.

Reddy S. , Bichler J. , Wells-Knecht K.J. , Thorpe S.R. , Baynes J.W. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995; 34: 10872–8.

Miyata T. , Fu M.X. , Kurokawa K. , van Ypersele de Strihou C. , Thorpe S.R. , Baynes J.W. Autooxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 1998; 54: 1290–5.

Miyata T. , Wada Y. , Kai Z. Implication of an increased oxidative stress in deformation of advanced glycation and products in patients with end-stage renal failure. Kidney Int 1997; 51: 1170–81.

Miyata T. , van Ypersele de Strihou C. , Kurokawa K. , Baynes J.W. Alterations in non-enzymatic biochemistry in uremia. Origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int 1999; 55: 389–99.

Park L. , Raman K.G. , Lee K.J. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Med 1998; 9: 1025–31.

Raj D.S.C. , Choudhury D. , Welbourne T.C. , Levi M. Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 2000; 35: 365–80.

Vlassara H. , Bucala R. , Stiker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138–51.

Motomiya Y. , Oyama N. , Iwamoto H. , Uchimura T. , Maruyama I. N-(carboxymethyl) lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis. Kidney Int 1998; 54: 1357–66.

Miyata T. , Ueda Y. , Saito A. , Kurokawa K. “Carbonyl stress” and dialysis-related amyloidosis. Nephrol Dial Transplant 2000; 15(suppl 1): 25–8.

Friedlander M.A. , Wu Y.C. , Schulak J.A. , Monnier W.M. , Hricik D.E. Influence of dialysis modalities on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995; 25: 445–51.

Kumano K. , Yokota S. , Sakai T. Kinetic analysis of furosine and pentosidine in CAPD patients. Adv Perit Dial 1997; 13: 53–7.

Miyata T. , Ueda Y. , Shinzato T. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with and-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996; 7: 1198–206.

Bonomini V. , Mioli V. , Albertazzi A. , Scolari P. Daily hemodialysis program: indications and results. Nephrol Dial Transplant 1998; 13: 2774–7.

Kooistra M.P. , Vos J. , Koomans H.A. , Vos P.F. Daily home hemodialysis in the Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13: 2853–60.

Fagugli R.M. , Buoncristiani U. , Ciao G. Anemia and blood pressure correction obtained by daily hemodialysis induce a reduction of left ventricle hypertrophy in dialysed patients. Int J Artif Organs 1998; 21: 429–31.

Buoncristiani U. , Fagugli R. , Ciao G. Left ventricle hypertrophy in daily hemodialysis. Miner Electrolyte Metab 1999; 25: 90–4.

Buoncristiani U. , Fagugli R. , Kulurianu K. , Carobi C. , Floridi A. Reduction of AGEs blood levels by daily hemodialysis (Abstract). Blood Purif 1997; 15(52) 43.

Vanholder R. , Hoefliger N. , De Smet R. , Ringoir S. Extraction of protein bound ligands from azotemic sera: comparison of 12 deproteinization methods. Kidney Int 1992; 41: 1707–12.

Odetti P. , Pronzato M.A. , Noberasco G. Relationships between glycation and oxidation related fluorescence in rat collagen during aging. Lab Invest 1994; 70: 61–7.

Yanagisawa K. , Makita Z. , Shiroshita K. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 1998; 47: 1348–53.

Dyer D.G. , Blackledge J.A. , Thorpe S.R. , Baynes J.W. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 1991; 266: 11654–60.

Floridi A. , Trizza V. , Paolotti P. , Lucarelli C. Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography. J Chromatogr A 1999; 846: 65–71.

Armitage P. , Berry G. The simple cross-over design. In: Armitage P. , Berry G. eds. Statistical methods in medical research, 3rd edition. Oxford: Blackwell Science Edt, 1994; 245–9.

Sakata S. , Takahashi M. , Kushida K. , Oikawa M. , Hoshino H. , Denda M. , Inoue T. The relationship between pentosidine and hemodialysis-related connective tissue disorders. Nephron 1998; 78: 260–5.

Miyata T. , Ueda Y. , Yamada Y. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 1998; 9: 2349–56.

Odetti P. , Cosso L. , Pronzato M.A. , Dapino D. , Guerreri G. Plasma advanced glycosylation end-products in maintenance hemodialysis patients. Nephrol Dial Transplant 1995; 10: 2110–3.

Miyata T. , Ueda Y. , Yoshida A. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 1997; 51: 880–7.

Makita Z. , Bucala R. , Rayfield E.J. Reactive glycosylation end products in diabetic uremia and treatment of renal failure. Lancet 1994; 343: 1519–22.

Jadoul M. , Veda Y. , Yasuda Y. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of “carbonyl stress”. Kidney Int 1999; 55: 2487–92.

Henle T. , Deppisch R. , Beck W. , Hergesell O. , Hansch G. , Ritz E. Advanced glycated end products (AGE) during hemodialysis: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant 1999; 14: 1968–75.